DE60310742D1 - Extrakt mit antitumoraler und antitoxischer wirkung - Google Patents

Extrakt mit antitumoraler und antitoxischer wirkung

Info

Publication number
DE60310742D1
DE60310742D1 DE60310742T DE60310742T DE60310742D1 DE 60310742 D1 DE60310742 D1 DE 60310742D1 DE 60310742 T DE60310742 T DE 60310742T DE 60310742 T DE60310742 T DE 60310742T DE 60310742 D1 DE60310742 D1 DE 60310742D1
Authority
DE
Germany
Prior art keywords
extracts
antitumoral
extract
antitoxic effect
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60310742T
Other languages
English (en)
Other versions
DE60310742T2 (de
Inventor
Francis Darro
Jean-Claude Braekman
Pierre Guissou
Germaine Nacoulma
Yazidi Mohamed El
Janique Dewelle
Ginkel Rob Van
Damme Marc Van
Robert Kiss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unibioscreen SA
Universite Libre de Bruxelles ULB
Original Assignee
Unibioscreen SA
Universite Libre de Bruxelles ULB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unibioscreen SA, Universite Libre de Bruxelles ULB filed Critical Unibioscreen SA
Publication of DE60310742D1 publication Critical patent/DE60310742D1/de
Application granted granted Critical
Publication of DE60310742T2 publication Critical patent/DE60310742T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medical Informatics (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60310742T 2002-10-09 2003-10-09 Extrakt mit antitumoraler und antitoxischer wirkung Expired - Lifetime DE60310742T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/EP2002/011310 WO2004032947A1 (en) 2002-10-09 2002-10-09 Extract with anti-tumor and anti-poisonous activity
WOPCT/EP02/11310 2002-10-09
PCT/EP2003/011192 WO2004032948A1 (en) 2002-10-09 2003-10-09 Extract with anti-tumor and anti-poisonous activity

Publications (2)

Publication Number Publication Date
DE60310742D1 true DE60310742D1 (de) 2007-02-08
DE60310742T2 DE60310742T2 (de) 2007-10-11

Family

ID=32087933

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60310742T Expired - Lifetime DE60310742T2 (de) 2002-10-09 2003-10-09 Extrakt mit antitumoraler und antitoxischer wirkung

Country Status (15)

Country Link
US (1) US20060057237A1 (de)
EP (1) EP1549329B1 (de)
JP (1) JP4944380B2 (de)
CN (1) CN100522184C (de)
AT (1) ATE349221T1 (de)
AU (2) AU2002342808A1 (de)
CA (1) CA2501240A1 (de)
DE (1) DE60310742T2 (de)
DK (1) DK1549329T3 (de)
ES (1) ES2279157T3 (de)
HK (1) HK1082663A1 (de)
MX (1) MXPA05003634A (de)
PT (1) PT1549329E (de)
WO (2) WO2004032947A1 (de)
ZA (1) ZA200502790B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0510036A (pt) * 2004-04-19 2007-10-02 All India Inst Med processo para preparar extrato de látex de calotropis procera, processo para preparar extratos de látex de calotropis procera, e, suspensão aquosa de látex seco de calotropis procera e método de preparação da mesma
CN101190210B (zh) * 2006-11-23 2010-05-12 樊献俄 三十烷醇在制备抗癌药物中的应用
CN101647790B (zh) * 2006-11-23 2011-10-26 樊献俄 三十烷醇在制备抗癌药物中的应用
CN101391998B (zh) * 2008-09-25 2012-07-04 成都普思生物科技有限公司 一种喜树碱的高效分离纯化方法
MY179036A (en) * 2012-12-13 2020-10-26 Malaysian Palm Oil Board Anti-proliferative effects of palm vegetation liquor and extracts thereof in preventing pancreatic cancer
CN104398532B (zh) * 2013-04-11 2017-02-22 中国热带农业科学院热带作物品种资源研究所 一种强心苷化合物的用途
US9533019B1 (en) * 2016-03-02 2017-01-03 King Saud University Calotropis procera extracts as anti-ulcerative colitis agents
IL256648A (en) 2017-12-28 2018-02-28 Ahava Dead Sea Laboratories Ltd Cosmetic preparations containing Sodom apple extract
US10111918B1 (en) 2018-03-02 2018-10-30 King Saud University Method of preparing biologically active derivatives from Calotropis gigantea flowers
CN111214478B (zh) * 2020-02-24 2023-08-08 海南医学院 弗如糖苷在制备治疗和/或预防滑膜相关疾病的药物中的用途
CN112194703B (zh) * 2020-09-03 2021-08-03 澳门科技大学 一种强心苷类化合物及其合成方法与应用
CN114831997A (zh) * 2022-06-07 2022-08-02 南昌大学第一附属医院 抑制结直肠癌细胞增殖药物及蒲公英甾醇的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904697A (en) * 1987-04-09 1990-02-27 Merrell Dow Pharmaceuticals Inc. Controlling the growth of certain tumor tissue with chalcone derivatives
CA2136091A1 (en) * 1992-05-20 1993-11-25 Daniel S. Martin Chemotherapeutic drug combinations
US5916596A (en) * 1993-02-22 1999-06-29 Vivorx Pharmaceuticals, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
GB9710698D0 (en) * 1997-05-24 1997-07-16 Verkaik Margaretha S E Composition
US8029561B1 (en) * 2000-05-12 2011-10-04 Cordis Corporation Drug combination useful for prevention of restenosis
CA2432792C (en) * 2000-12-22 2012-04-03 Bristol-Myers Squibb Company Methods for modulating tumor growth and metastasis

Also Published As

Publication number Publication date
AU2002342808A1 (en) 2004-05-04
AU2003273973A1 (en) 2004-05-04
WO2004032948A1 (en) 2004-04-22
ZA200502790B (en) 2006-02-22
CN100522184C (zh) 2009-08-05
JP4944380B2 (ja) 2012-05-30
WO2004032947A1 (en) 2004-04-22
JP2006503872A (ja) 2006-02-02
ES2279157T3 (es) 2007-08-16
PT1549329E (pt) 2007-03-30
DK1549329T3 (da) 2007-05-07
CN1711099A (zh) 2005-12-21
EP1549329B1 (de) 2006-12-27
AU2003273973B2 (en) 2008-11-20
DE60310742T2 (de) 2007-10-11
ATE349221T1 (de) 2007-01-15
MXPA05003634A (es) 2005-12-14
US20060057237A1 (en) 2006-03-16
CA2501240A1 (en) 2004-04-22
HK1082663A1 (en) 2006-06-16
EP1549329A1 (de) 2005-07-06

Similar Documents

Publication Publication Date Title
HK1082663A1 (en) Extract with anti-tumor and anti-poisonous activity
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
BRPI0413427A (pt) derivados de piridilpirrol ativos como inibidores da cinase
MXPA02012164A (es) Derivados de tiofeno activos como inhibidores de cinasa, proceso para su preparacion y composiciones farmaceuticas que los comprenden.
ATE334985T1 (de) Verbindungen, verfahren und pharmazeutische zubereitungen zur behandlung von zellschäden wie zum beispiel schäden an nerven- oder kerzgefässgewebe
MXPA06000302A (es) Derivados de pirazolil-indol activos como inhibidores de cinasa, procedimientos para su preparacion y composiciones farmaceuticas que los comprenden.
ATE332136T1 (de) Mittel, wie nikotinamide oder cadpr zur behandlung von hautkrankheiten
BRPI0413438A (pt) derivados de pirimidilpirrol ativos como inibidores de cinase
NO20071798L (no) Dermalt pafore formuleringer for behandling av hudsykdommer i dyr
PT1212312E (pt) Novos derivados de flavonas xantonas e cumarinas
SE9802208D0 (sv) Novel compounds
IL162384A0 (en) Composition inhibiting matrix-metallproteinases for the treatment of neoplastic diseases
IL163951A (en) Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
EP1178796A4 (de) Aminoimidazolcarboxamidesalze zur vorbeugung und behandlung von leberkrankheiten
ATE319473T1 (de) Melagatran zur behandlung von entzündungen
NO20051261L (no) Morfin-6-glukuronidsalt
DK1237562T3 (da) Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme
ATE414100T1 (de) Zielgerichtete ligande gegen peyer's flecke- und/oder m-zellen
SE9802209D0 (sv) Novel compounds
MY133682A (en) Substituted pyrroles
DE60221104D1 (de) Substituierte diarylharnstoffe als stimulatoren der fas-vermittelten apoptose
DK1523985T3 (da) Ikke-radioaktivt strontiumholdigt middel til behandling af kræft
MX2022006052A (es) Inhibidores de la caspasa 6 y usos de los mismos.
WO2001093889A3 (en) Vip-related peptides for the treatment of skin disorders
DE50304524D1 (de) Arzneimittel enthaltend substituierte 2,5-diaminomethyl-1h-pyrrole

Legal Events

Date Code Title Description
8364 No opposition during term of opposition